Form 8-K - Current report:
SEC Accession No. 0001104659-24-110891
Filing Date
2024-10-23
Accepted
2024-10-23 17:16:50
Documents
17
Period of Report
2024-10-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2426723d1_8k.htm   iXBRL 8-K 36000
2 EXHIBIT 1.1 tm2426723d1_ex1-1.htm EX-1.1 299603
3 EXHIBIT 4.1 tm2426723d1_ex4-1.htm EX-4.1 71538
4 EXHIBIT 5.1 tm2426723d1_ex5-1.htm EX-5.1 12100
8 GRAPHIC tm2426723d1_ex5-1img001.jpg GRAPHIC 5694
  Complete submission text file 0001104659-24-110891.txt   701607

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tela-20241023.xsd EX-101.SCH 3012
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tela-20241023_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tela-20241023_pre.xml EX-101.PRE 22357
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2426723d1_8k_htm.xml XML 3915
Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Filer) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39130 | Film No.: 241390040
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)